GROUP PROTOCOL FOR THE MANAGEMENT OF SIMPLE MOUTH ULCERS. Version 4 December 2017

Similar documents
GROUP PROTOCOL FOR THE MANAGEMENT OF SIMPLE INDIGESTION. Version 5 December 2017

GROUP PROTOCOL FOR THE MANAGEMENT of HEARTBURN and ACID REFLUX. Version 4 January 2014

Patient Group Direction for the supply of Fusidic Acid Cream 2% to patients aged over 2 years old receiving treatment from NHS Borders.

NHS Lothian Patient Group Direction Version: 001

Supply of Fusidic Acid Cream 2% by Community Pharmacists for the treatment of impetigo in patients 2 years of age and over.

PATIENT GROUP DIRECTION

Supply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 version 1

Job Title Name Signature Date

Patient Group Direction For the supply of Fusidic Acid 2% Cream

Supply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 version 2

Expiry Date: January 2009 Template Version: Page 1 of 7

Name Job Title Signed Date. This Patient Group Direction is operational from: Oct 2017 Review date: Aug 19. Expires on 31 st October 2019

Please call the Pharmacy Medicines Unit on or for a copy.

PROTOCOL FOR THE ADMINISTRATION OF SENNA. Formulary and Prescribing Guidelines

Page 17. Medication Management Policy and Practice Guidelines

PATIENT GROUP DIRECTION (PGD) FOR THE SUPPLY OF DOXYCYCLINE 100MG CAPSULES / TABLETS FOR THE FIRST- LINE TREATMENT OF CHLAMYDIA TRACHOMATIS INFECTION

PROCEDURE FOR THE ADMINISTRATION OF HOMELY REMEDIES IN COMMUNITY HOSPITALS

Guidance on the prescribing of medication initiated or recommended either after a private episode of care or a referral to a tertiary NHS centre

IBUPROFEN PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

Name Job Title Signed Date

xrfslt \j,3 0+ {6^1 Otc(L!?i:lr+ NHS FIFE PRIMARY CARE THIS PATIENT GROUP DIRECTION HAS BEEN APPROVED BY:

Document Details. notification of entry onto webpage

THE TREATMENT OF BACTERIAL VAGINOSIS (BV) OR TRICHOMONAS VAGINALIS

Patient Group Direction for Aspirin 300mg Version: 02 Start Date: 1 st October 2017 Expiry Date: 30 th September 2019

Document Details. Patient Group Direction

NHS Fife. Patient Group Direction for Named Community Pharmacists to Supply

Medication Policy. Linked to National Quality Standards- Quality Area Two: Element Policy statement

Nasogastric tube feeding

Newfoundland and Labrador Pharmacy Board

PATIENT GROUP DIRECTION. Hepatitis A + B Vaccine (Twinrix, Twinrix paediatric, Ambirix )

Expiry Date: January 2009 Template Version: Page 1 of 7

Appendix 3 Cardiac Catheter Lab at Musgrove Park Hospital PATIENT GROUP DIRECTION (PGD)

Symptomatic Relief Policy Compiled by: Drug Adminstration Steering Group Date: July 2004 Review Date: July 2006

CLINICAL GUIDELINE FOR IPRATROPIUM BROMIDE NEBULISER INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

The use of Homely Remedies in Care Homes

Temporary Exclusion for Health Reasons (Including Medications and Special Diets) Policy

PARACETAMOL PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

National Emergency Medicine Programme. Protocol for the administration of Paracetamol (Acetaminophen) at Triage in the Emergency Department

Health Authority Abu Dhabi

Fundamentals of Care. Do you receive care Do you know what to expect? Do you provide care? Quality of care for adults

Save up to $4,000 a year?!

Dr Vincent Kirchner, MEDICAL DIRECTOR. Date Version Summary of amendments Oct New Procedure

GG&C PGD ref no: 2017/1426 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

Patients Own Medications Policy

KING S HOUSE SCHOOL FIRST AID & MEDICINES AND MEDICAL CONDITIONS MANAGEMENT POLICY

Consultation Group: See relevant page in the PGD. Review Date: October 2015

Croydon Health Services NHS Trust (Working in Partnership) Shared Care Guideline: Prescribing Agreement

Patient Group Direction for ACICLOVIR (Version 02) Valid From 1 October September 2019

CLINICAL PROTOCOL FOR THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT GROUP DIRECTIONS (PGD)

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Unlicensed Medicines Policy Document

The Children s Hospital, Oxford. Tonsil Surgery (Tonsillectomy) Information for parents and carers

Patient Group Direction (PGD) template

2. Short term prescription medication and drugs (administered for less than two weeks):

FOR MEDICINE ADMINISTRATION IN COMMUNITY NURSING

New v1.0 Date: Cathy Riley - Director of Pharmacy Policy and Procedures Committee Policy and Procedures Committee

Standard Operating Procedure for When required (PRN) medicines in care homes

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PEGYLATED LIPOSOMAL DOXORUBICIN (CAELYX)

Best Practice Guidance for GP Practices, Community Pharmacists and Care Home Providers

RULE RESPONSIBILITIES OF A PHYSICIAN WHO ENGAGES IN DRUG THERAPY MANAGEMENT WITH A COLORADO LICENSED PHARMACIST

Reduce general practice consultations and prescriptions for minor conditions suitable for self-care

PATIENT GROUP DIRECTION (PGD) FOR

Sentinel node biopsy. Patient Information to be retained by patient

Procedure to Allow Nursing Staff to Dispense Leave and Discharge Medication

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

After your child s Jejunostomy Discharge Information

1. Guidance notes. Social care (Adults, England) Knowledge set for medication. What are knowledge sets? Why were knowledge sets commissioned?

Meet the Pharmacy Team Experts in Medicine. Pharmacy Department

Template (to be adapted by care home) Medication to be administered on a PRN (when required) basis in a care home environment

Patient Self Administration of Intravenous (IV) Antibiotics at Home

BEST PRACTICE GUIDANCE-SUPPLEMENTARY PRESCRIBING

Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE. SECTION 9(a) UNLICENSED MEDICINES

Section 7: Core clinical headings

Medicine Protocol for the Administration of Inactivated Influenza Vaccine (Split Virion) BP Version 1, June 2017

Medication Management Policy and Procedures

Excision of Submandibular Gland

GG&C PGD ref no: 2011/841 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

SELF - ADMINISTRATION OF MEDICINES AND ADMINISTRATION OF MEDICINES SUPPORTED BY FAMILY/INFORMAL CARERS OF PATIENTS IN COMMUNITY NURSING

Non-Medical Prescribing Passport. Reflective Log And Information

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CHOP 21 + RITUXIMAB

Percutaneous Endoscopic Gastrostomy (PEG)

Maryland. Prescribing and Dispensing Profile. Research current through November 2015.

PATIENT GROUP DIRECTION (PGD) FOR Metronidazole 400mg Tablets

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Non Medical Prescribing Policy Register No: Status: Public

MEDICINES RECONCILIATION GUIDELINE Document Reference

Patient information. Axillary Node Surgery (Operations on the Armpit) Breast Directorate PIF 1370 V3

The Children s Hospital Children s Day Care Ward, Tom s Ward. Labial Adhesions. Information for parents and carers

PATIENT AGREEMENT TO SYSTEMIC THERAPY: GENERIC CONSENT FORM. Patient s first names. Date of birth. Job title

First Aid and Medicine Policy. Date Adopted: May Next Review Date: May 2021

DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR MEDICARE & MEDICAID SERVICES

The Medicines Policy. Chapter 6: Standards of Practice. MISCELLANEOUS and DISCHARGE

NHS GREATER GLASGOW AND CLYDE POLICIES RELATING TO THE MANAGEMENT OF MEDICINES SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION)

City. Whom may we thank for referring you to us?

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

Patient Group Direction For The Administration Of Sodium Chloride (0.9%) Via Nebulisation By Physiotherapists Working Within NHS Grampian

Having an endoscopic retrograde cholangio-pancreatograph (ERCP)

MEDICATION MONITORING AND MANAGEMENT Procedures

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM DOCETAXEL + PREDNISOLONE. Patient s first names

Pressure Ulcer Prevention

Transcription:

GROUP PROTOCOL FOR THE MANAGEMENT OF SIMPLE MOUTH ULCERS Version 4 December 2017 RATIFYING COMMITTEE Drugs and Therapeutics Group DATE RATIFIED MAUP EXPIRES December 2020 EXECUTIVE SPONSOR Chief Nurse MAUP ORIGINAL AUTHOR Louise Noble - Pharmacist REVIEWED BY Mel Stubbs Pharmacy Technician KEY POLICY ISSUES: Key indication for the use of Bonjela oral gel Staff eligible to work under the protocol If you require this document in an alternative format, ie easy read, large text, audio, Braille or a community language please contact the Pharmacy Team on 01243 623349.

GROUP PROTOCOL FOR THE MANAGEMENT OF SIMPLE MOUTH ULCERS Version : 4 December 2017 Group Protocol drawn up by: Name Title Louise Noble Pharmacist Group Protocol authorised by: (on behalf of the Trust). Chief Medical Officer Chief Nurse Chief Pharmacist Rick Fraser Diane Hull Ray Lyon Appointed Practitioner in Charge (on behalf of the ward) Date Protocol agreed December 2017 Proposed review date December 2020 Date Protocol expires December 2020 Ward Protocol relates to

GROUP PROTOCOL FOR THE MANAGEMENT OF SIMPLE MOUTH ULCERS 1. CLINICAL CONDITION 1.1 Clinical condition Mouth ulcer or denture sore (as assessed using nurse s clinical judgement) warranting treatment with Bonjela oral gel. 1.2 Inclusion Criteria Patients with a mouth ulcer or denture sore - (adults and children over 16 years of age). 1.3 Exclusion Criteria First ever mouth ulcer If the ulcer is deep and has an uneven discolouration If the ulcer is not causing any pain or discomfort If the ulcer has been present for more than three weeks If the ulcer is greater than 1cm across If the patient has a stomach ulcer If the patient is allergic to salicylates e.g. aspirin If the patient is under 16 years of age If the patient is pregnant If the patient has known sensitivity to Bonjela oral gel If the patient has an intolerance or hypersensitivity to ethanol.

1.4 Action to be taken if patient is excluded from treatment under protocol Consult with ward Medical Officer 9.00 am 5.00 pm Monday to Friday. Contact duty Medical Officer out of hours if persistent or extreme discomfort warrants. 1.5 Action to be taken if patient refuses treatment under protocol Discuss with the Ward Medical Officer if pain persists and nursing staff have significant concerns. 2. STAFF AND LOCATION 2.1 Location 2.2 Staff Inpatient units - Trustwide. Qualified nursing staff that have been signed off as competent by the Appointed Practitioner in Charge of the ward following training and successful completion of the 'Key Aspects of Pharmacy' questionnaire for Bonjela oral gel. 2.3 Continued Training Requirements. It should be highlighted to medical and nursing staff that Bonjela oral gel should not be given to children under 16 years of age. This is because there is a possible association between salicylates (contained in Bonjela oral gel) and Reye s syndrome, when given to children. Reye s syndrome is a rare, potentially fatal disease that affects the brain and liver. 3 TREATMENT 3.1 Name of medicine Bonjela oral gel 3.2 Legal status (POM, P or GSL) GSL (General sales list) 3.3 Dose or dose range and criteria for determining dose Massage approximately 1cm of gel onto the sore area. If using for denture sores then leave at least 30 minutes before reinserting the dentures. (Do not apply Bonjela oral gel directly to the dentures). 3.4 Method of route of administration Topical application

3.5 Frequency of administration Every three hours as needed. Maximum period of continuous treatment must not exceed seven days without a medical review of the underlying symptoms. NB. Bonjela tubes should not be shared amongst patients. There must be one tube in use per patient. This should be labelled with their name and the date of opening and must be disposed of when treatment is complete. 3.6 Follow up treatment None 3.7 Side effects and potential drug interactions Side effects are rare. Glycerol may cause headache, stomach upset and diarrohea in high doses. 3.8 Instruction on identifying and managing possible adverse outcomes Normal ward observations. If there is a decline in the patient s physical condition or the nurse suspects an adverse reaction, contact the ward Medical Officer or duty Medical Officer. Document concerns in patients notes. 3.9 Arrangement for referral to medical advice Contact ward Medical Officer in normal working hours. Contact duty Medical Officer outside working hours. 4. INFORMATION AND DOCUMENTATION 4.1 Advice (including written advice) to be given to patient or carer before or after treatment. Confirm no history of sensitivity to Bonjela oral gel or salicylates. Verbal instruction on drug being administered. Offer leaflet patient information on mouth ulcers if appropriate. See appendix. 4.2 Details of treatment records required Completion of MAUP section on the patient s drug chart.

Record entry in Carenotes. This should record the presence of a mouth ulcer, and administration of Bonjela oral gel in line with MAUP (or equivalent statement). 5. MANAGEMENT AND MONITORING 5.1 Advisory group approving the protocol Drugs and Therapeutics Group. 5.2 Lines of accountability Clinical Service Managers. 5.3 Method to report any adverse drug reactions to the doctor Normal ward policy for communicating with the Medical Officer. 5.4 Audit Arrangements Pharmacy supervision. Clinical audit. 5.5 Review Date and by Whom Every two years by the Drugs and Therapeutics Group, or earlier if significant new evidence or manufacturers advice on use of Bonjela oral gel becomes available.

6. Staff authorized to work under the Group Protocol I have read the group protocol and agree to use it: - Nurses agreeing to and authorized to work under the protocol Appointed Practitioner in Charge assessing competence Name Signature Name Signature Date

KEY ASPECTS OF PHARMACY QUESTIONNAIRE (To be completed without access to the Protocol or drug text books, eg BNF.) Key aspects of pharmacy for Bonjela oral gel Professional's name: Grade: 1. Symptoms/criteria under which the patient will be eligible for treatment under the Protocol 2. Forms and strengths available 3. Mode of action 4. Exclusion criteria 5. Dose 6. Route of administration 7. What potentially significant side effects and drug interactions are there? 8. What written/verbal advice must be given to the patient/carer on the identification and management of significant potential side effects? I confirm that at the time of completion the answers provided showed an acceptable level knowledge. Name: Designation: Signature: Date:

Patient Information on mouth ulcers A mouth ulcer is a painful sore in the mouth. They can occur singly or in clusters, causing a lot of discomfort or pain. Mouth ulcers normally heal within 7 to 10 days. They are different from cold sores that appear on the outer lips due to a viral infection. Symptoms Mouth ulcers may be round or oval with shallow, white, grey or yellow spots with an inflamed border. They cause discomfort or pain, particularly in response to eating certain foods. The most painful stage lasts for three or four days and then the symptoms settle until the ulcers heal. In severe attacks you may feel sick and have a slight fever. You may have painful, enlarged lymph glands around your jaw in the upper part of your neck. Causes Recurrent mouth ulcers cannot be caught by kissing or by sharing drinks/utensils because they are not caused by an infectious agent (they are not contagious). Recurrent mouth ulcers may be due to stress, generalised infections, hormonal changes, too little iron or a lack of vitamins in the diet (especially B12 and C), sensitivity to foods containing some preservatives and flavouring agents, bowel diseases or skin diseases. Some medicines can also cause mouth ulcers. Treatment Treatment involves reducing pain caused by the ulcer. Keep your mouth clean. Avoid foods that are spicy, acidic, salty or particularly hot or cold. Eat a healthy diet. Gargle with warm salt water. Various products are available without a prescription (e.g. Bonjela oral gel which helps to relieve pain caused by the ulcer). Not all products are suitable for the treatment of children. You can obtain more advice from your doctor or nurse, or from a member of the pharmacy team. If the ulcer does not heal either after seven days of continuous treatment or within three weeks if untreated, then speak to a doctor or dentist to check there is not an underlying medical cause. If you require this document in an alternative format, ie easy read, large text, audio, Braille or a community language please contact the Pharmacy Team on 01243 623349. Reviewed unchanged 2017